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To assess the degree of intra-host variability in C2-C4 regions of gp120
To establish whether (and to which extent) differences existed in number and distribution of potential N-linked glycosylation sites (PNGSs) in these regions To characterize potential relationships among intra-host variability in C2-C4, antiretroviral treatment and stage of the infection (acute vs. early chronic)
A C2-C4 fragment from HIV plasma RNA was cloned and sequenced in 12 patients. Extensive indel-associated variability was observed in V4 at intra-host level. Indels, coupled to aa substitutions, generated V4 subsets differing in size, aa sequence and potential N-glyc patterns. V3 was found to be relatively homogeneous, with similar V3 associated to highly different V4 within the same clinical specimen. Based on these data, we propose that during early infection HIV-1 gp120 is present as a swarm of different molecules. The swarm would act as a glycan shield, enabling the virus to replenish the viral load with new V4 variants should the predominant variant be neutralized by the host immune system.
Relative frequencies of V3 and V4 before and after Antiretroviral treatment (Patient 11)
Shot-gun cloning and sequencing of and env fragment spanning gp120 regions C2-C4.
Phylogenetic Analysis
Intra-patient clonal analysis of C2-C4 HIV-1 envelope sequence distances.
Consensus sequences from each patient emerge from a unique branch with the exception of a transmission pair (Pts. 6 and 9). V4 was found to be highly heterogeneous in length due to indels of various sizes Indels always involved a number of bp equal to or multiple of 3 Indels, together with aa substitutions, affected the patterns of PNGSs in V4 Clones carrying highly divergent V4 were characterized by similar to identical V3
No conclusive correlation could be established between treatment and V4 polymorphism No length polymorphism was ever found during primary infection Trends of V3-V4 unpaired quasispecies evolution were confirmed in patients harboring HIV-1 B and non-B clades
